What is the monitoring plan for labs, side effects, and outcomes
Given the human trials in early 2000s showed no adverse events, despite using enormous doses, and the animal data corroborating this, many practitioners feel comfortable prescribing/recommending BPC-157 (I am not making such a recommendation)
For individuals who are uncomfortable with needles, capsules offer a non-invasive alternative that still provides the healing benefits of BPC-157
However, more profound studies in the matter are necessary
With DSIP being largely relegated to laboratory use, theres currently no standard protocol for its use among humans
Review Article - (2016) Volume 8, Issue 2 John W Wright 1,2* and Joseph W Harding 1,2 1 Departments of Psychology and Integrative Physiology and Neuroscience, and Program in Biotechnology, Washington State University, Pullman, WA, USA 2 M3 Biotechnology, Inc., Seattle, WA, USA Received May 02, 2016